Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges and opportunities in NASH drug development.
Harrison SA, Allen AM, Dubourg J, Noureddin M, Alkhouri N. Harrison SA, et al. Among authors: dubourg j. Nat Med. 2023 Mar;29(3):562-573. doi: 10.1038/s41591-023-02242-6. Epub 2023 Mar 9. Nat Med. 2023. PMID: 36894650 Review.
Prognostic value of troponins in sepsis: a meta-analysis.
Bessière F, Khenifer S, Dubourg J, Durieu I, Lega JC. Bessière F, et al. Among authors: dubourg j. Intensive Care Med. 2013 Jul;39(7):1181-9. doi: 10.1007/s00134-013-2902-3. Epub 2013 Apr 18. Intensive Care Med. 2013. PMID: 23595497 Review.
Pituitary surgery: legacies from the past.
Dubourg J, Jouanneau E, Messerer M. Dubourg J, et al. Acta Neurochir (Wien). 2011 Dec;153(12):2397-402. doi: 10.1007/s00701-011-1107-1. Epub 2011 Aug 11. Acta Neurochir (Wien). 2011. PMID: 21833782
Cerebellopontine angle cyst.
Messerer M, Dubourg J, Hamlat A. Messerer M, et al. Among authors: dubourg j. J Neurosurg Pediatr. 2011 Sep;8(3):335; author reply 335-6. doi: 10.3171/2011.5.PEDS11134. J Neurosurg Pediatr. 2011. PMID: 21882929 No abstract available.
Efficacy and safety of PXL770, a direct AMP kinase activator, for the treatment of non-alcoholic fatty liver disease (STAMP-NAFLD): a randomised, double-blind, placebo-controlled, phase 2a study.
Cusi K, Alkhouri N, Harrison SA, Fouqueray P, Moller DE, Hallakou-Bozec S, Bolze S, Grouin JM, Jeannin Megnien S, Dubourg J, Ratziu V. Cusi K, et al. Among authors: dubourg j. Lancet Gastroenterol Hepatol. 2021 Nov;6(11):889-902. doi: 10.1016/S2468-1253(21)00300-9. Epub 2021 Sep 22. Lancet Gastroenterol Hepatol. 2021. PMID: 34560015 Clinical Trial.
38 results